EFFECT OF ZIDOVUDINE ON SERUM HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN LEVELS IN SYMPTOM-FREE SUBJECTS

This publication has 14 references indexed in Scilit:

• Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia.
  BMJ, 1987
• Temporal relation of antigenaemia and loss of antibodies to core antigens to development of clinical disease in HIV infection.
  BMJ, 1987
• The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
  New England Journal of Medicine, 1987
• Intra-blood-brain barrier synthesis of human immunodeficiency virus antigen and antibody in humans and chimpanzees.
  Proceedings of the National Academy of Sciences, 1987
• RESPONSE OF HUMAN-IMMUNODEFICIENCY-VIRUS-ASSOCIATED NEUROLOGICAL DISEASE TO 3'-AZIDO-3'-DEOXYTHYMIDINE
  The Lancet, 1987
• Significant Changes in HIV Antigen Level in the Serum of Patients Treated with Azidothymidine
  New England Journal of Medicine, 1986
• Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.
  BMJ, 1986
• EXPRESSION OF HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN (HIV-Ag) IN SERUM AND CEREBROSPINAL FLUID DURING ACUTE AND CHRONIC INFECTION
  The Lancet, 1986
• ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX
  The Lancet, 1986
• 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.
  Proceedings of the National Academy of Sciences, 1985